yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33412801-046B1383-7B8B-4E65-AAA6-2BF22E51E3F8
Q33412801-046B1383-7B8B-4E65-AAA6-2BF22E51E3F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33412801-046B1383-7B8B-4E65-AAA6-2BF22E51E3F8
Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.
P2860
Q33412801-046B1383-7B8B-4E65-AAA6-2BF22E51E3F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33412801-046B1383-7B8B-4E65-AAA6-2BF22E51E3F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46b92cf7cc22ae18fb76a10fbb94e07ce2a02534
P2860
Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas